Skip to main content

Advertisement

Table 3 Treatment responses in 59 patients

From: Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial

Treatment response After two cycles of ICT No. (%) After CRT No. (%) Three months after CRT No. (%)
Complete response (CR) 8/59(13.6) 47/59(79.7) 51/59(86.4)
Partial response (PR) 44/59(74.6) 12/59(20.3) 2/59(3.4)
Stable disease (SD) 4/59(6.8) 0/59(0) 0/59(0)
Not available 3/59(5.1) 0/59(0) 6/59(10.2)
Objective response (CR + PR) 52/59(88.1) 59/59(100) 53/59(89.8)
95% CI of ORR (0.77, 0.95) NA (0.82, 0.98)
  1. Abbreviation ICT induction chemotherapy; CRT concurrent chemoradiotherapy; CI confidence interval; ORR objective response rate; NA not available